CELG RT — Bristol-Myers Squibb Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapSuper Stock

Annual balance sheet for Bristol-Myers Squibb Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	fx Preliminary
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17,221	9,253	12,280	10,859	—
Net Total Accounts Receivable
Net Total Receivables	12,516	13,937	15,264	14,424	—
Total Inventory
Total Other Current Assets
Total Current Assets	33,262	27,273	31,770	29,780	—
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,968	7,475	8,036	8,360	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	109,314	96,820	95,159	92,603	—
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	21,868	21,890	22,262	23,774	—
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	73,368	65,759	65,729	76,268	—
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	35,946	31,061	29,430	16,335	—
Total Liabilities & Shareholders' Equity	109,314	96,820	95,159	92,603	—
Total Common Shares Outstanding